STDs
The Baltimore-based firm is developing multiplex molecular tests for sexually transmitted disease identification and drug susceptibility characterization.
CARB-X Awards $1M Each to Prompt Diagnostics, Fuse Diagnostics for Point-of-Care STI Tests
The funds will support the development of Prompt's test for drug resistant Neisseria gonorrhoeae and Fuse's test for N. gonorrhoeae and Chlamydia trachomatis.
Wastewater Surveillance of Chlamydia in Las Vegas Finds Peaks After Holidays, Major Sporting Events
The analysis, presented at ASM Microbe, also found that wastewater detection of the pathogen preceded increased numbers of clinically reported cases.
Binx Health Raises $65M in Series F Financing Round
The money raised in the Series F round will be used for commercial growth, sales support, and scaling up manufacturing.
OraSure Technologies Beats Q4 Revenue Estimates, Inks Distribution Deal for Syphilis Rapid Test
The company also said it will distribute Diagnostics Direct's Syphilis Health Check rapid diagnostic test under a new agreement.